Abstract
G protein-coupled receptors (GPCRs) transduce various extracellular signals, such as neurotransmitters, hormones, light, and odorous chemicals, into intracellular signals via G protein activation during neurological, cardiovascular, sensory and reproductive signaling. Common and unique features of interactions between GPCRs and specific G proteins are important for structure-based design of drugs in order to treat GPCR-related diseases. Atomic resolution structures of GPCR complexes with G proteins have revealed shared and extensive interactions between the conserved DRY motif and other residues in transmembrane domains 3 (TM3), 5 and 6, and the target G protein C-terminal region. However, the initial interactions formed between GPCRs and their specific G proteins remain unclear. Alanine scanning mutagenesis of the murine olfactory receptor S6 (mOR-S6) indicated that the N-terminal acidic residue of helix 8 of mOR-S6 is responsible for initial transient and specific interactions with chimeric Gα15_olf, resulting in a response that is 2.2-fold more rapid and 1.7-fold more robust than the interaction with Gα15. Our mutagenesis analysis indicates that the hydrophobic core buried between helix 8 and TM1–2 of mOR-S6 is important for the activation of both Gα15_olf and Gα15. This review focuses on the functional role of the C-terminal amphipathic helix 8 based on several recent GPCR studies.
Keywords: G protein-coupled receptor, olfactory receptor, activation, interaction, Ca2+ imaging, response kinetics, homology model
1. Introduction
G protein-coupled receptors (GPCRs) form a large protein superfamily comprising nearly 800 members in humans [1]. GPCRs are mainly located in the plasma membrane, where they detect various extracellular physicochemical signals from inside the body or from external environments such as neurotransmitters, hormones, light, and odorous chemicals during neurological, cardiovascular, sensory and reproductive signaling processes via activation of respective target G protein α subunits (Gαs) and their effector proteins for intracellular signals. GPCR signaling systems are involved in many diseases, and some are major therapeutic targets [2]. Due to their abundance and variability, GPCR signaling is highly diverse in terms of ligands, ligand-binding sites, GPCR-specific Gα subunits, and downstream effector proteins. In contrast, the intramolecular interactions underpinning the structural rearrangements of activated GPCRs [3,4] and the essential and extensive interactions between activated GPCR and Gα [5,6] are conserved, at least for class A GPCR signaling. Activation of a specific Gα appears to be mediated by the formation of initial transient and type-specific interactions with activated GPCRs prior to the formation of more stable interactions. This initial transient process can be a potential target for specific GPCR-regulated signaling pathways.
Recently, we found that the second residue of the amphipathic helix 8 in the C-terminal domain of the murine olfactory receptor S6 (mOR-S6), a GPCR superfamily member, is responsible for initial transient and specific interactions with chimeric Gα15_olf, but not with Gα15 [7]. Our mutagenesis analysis also indicates that the hydrophobic core that is buried between the amphipathic helix 8 and transmembrane domains 1–2 (TM1–2) of mOR-S6 are important for activation of both Gα15_olf and Gα15. In many GPCRs, helix 8 plays several key roles in protein/lipid interaction [8,9], receptor internalization [10], dimerization of receptors [11], and coupling with G proteins [12]. By comparing several GPCRs, this review focuses on the functional roles of the C-terminal amphipathic helix 8 of olfactory receptors (ORs) and other GPCRs.
2. A Simple Model of Signal Flow via Interactions in Parallel G Protein-Coupled Receptor (GPCR) Signaling Pathways
GPCR signaling pathways involve the activation of various signaling proteins through key molecular interactions. We considered a simple model of signal flow that proceeds via interactions in parallel GPCR signaling pathways. This is one possible model and does not exclude other mechanisms. In general, the basic principles governing various physicochemical phenomena should be simple and hierarchically assembled, and the molecular mechanisms underpinning the interactions of GPCRs with their ligands or G proteins should be also hierarchically assembled. Intra- and inter-molecular interactions of GPCRs are classified as shared or type-specific across all GPCRs or individual GPCR sub-superfamilies, and interactions are classified as transient or (more) stable. In each step, a specific interaction with a higher binding affinity of a ligand for a receptor is of higher priority. Evidence suggests that initial transient and specific interactions facilitate the shared, extensive (more stable) and partially type-specific interactions [4,5,7], but not vice versa (i.e., shared interactions do not facilitate specific interactions in our model).
GPCRs consist of seven transmembrane-spanning α-helices connected by extracellular loops (EC, including an N-terminus) or intracellular loops (IC, including a C-terminus that contains a short α-helix, helix 8). The concentration of a signaling molecule is highest at its source and gradually increases from nearly zero to a peak value in the vicinity of a GPCR at the membrane of a cell. A given signal molecule is likely to bind to a specific binding site of its target GPCR with a higher affinity than for a nonspecific binding site or to a non-target GPCR. As the concentration of the signaling molecule increases, the agonist-specific interaction results in the target GPCR becoming semi-activated before non-target GPCRs. In order to maintain the activated structural conformation for an adequate time period (being more stable), the initial specific interactions with the agonist facilitate the formation of intramolecular interactions in the activated GPCR, and these are likely to be shared among different GPCR family members. In the next step, the activated GPCR interacts with specific sites or residues of its target G protein, also in an affinity-dependent manner, rather than with non-specific interaction sites of target G proteins or with conserved residues of non-target G proteins. Similarly, in order for semi-activated GPCRs to form extensive interactions with their target G proteins for an adequate period of time to allow the exchange of guanosine 5′-diphosphate (GDP) for guanosine triphosphate (GTP), a second set of specific and transient interactions presumably facilitate the formation of the GPCR–G protein complex in a fully activated form, and these more stable intermolecular interactions are likely to be shared, at least in part, between different GPCRs. In parallel GPCR signaling pathways, specific activation sequences enable target GPCRs to first detect signaling molecules and activate target G proteins, and also to initiate activation or inactivation of specific effector proteins to bring about the desired function. This avoids functional disorders resulting from stimulation or inactivation of non-target effector proteins. This functional model allows us to predict intra- and inter-molecular interactions, as follows:
-
(1)
An agonist molecule binds to a specific binding site of a target GPCR (first semi-activation).
-
(2)
Binding of a specific agonist induces the structural rearrangement of GPCR transmembrane domains, leading to conformational changes and transition to an active state (activation by an agonist).
-
(3)
The activated GPCR initially and transiently interacts with a target heterotrimeric G protein [7] comprised of α-, β- and γ-subunits (second semi-activation).
-
(4)
In the initial and transient interaction between the GPCR and a semi-activated target G protein, displacement of helix-α5 of the Gα subunit towards TM3 of the GPCR facilitates the formation of a more stable, ternary activated GPCR–heterotrimeric G protein complex that is mediated by shared and/or partially specific molecular interactions [5] (full activation).
-
(5)
In the stable, ternary activated GPCR–heterotrimeric G protein complex, the Gα subunit releases GDP from the binding pocket.
-
(6)
A GTP then binds to the nucleotide-free Gα subunit, followed by dissociation of Gα and βγ subunits from the GPCR [5].
-
(7)
The Gα and βγ subunits interact with their respective effector proteins, thereby regulating their activities in the process.
As described above, steps (1) and (3) are likely to be specific to a target GPCR or G protein, whereas steps (2) and (4) are likely to be shared between different GPCRs and G proteins.
3. Structural Features of Helix 8
The most important structural feature of helix 8 is an amphipathic short α-helix. In rhodopsin (Rhod), helix 8 acts as a membrane surface recognition domain, and adopts a helical structure only in the presence of membranes or membrane mimetics [9]. Helix 8 begins after a short linker following TM7, at the end of which the conserved NPxxY motif is located, as shown in a selection of class A GPCR sequences (Figure 1) [3,4,5,6,7]. The short linker between TM7 and helix 8 is also important, as described in Section 5 below. Crystal structures revealed that helix 8 lies parallel to the membrane in both inactive and active states in the β2 adrenergic receptor (β2AdR) and in Rhod [5,13,14,15]. Moreover, in the inactive state of these GPCRs, the third residue (Phe) of helix 8 interacts with the Tyr residue of the NPxxY motif in TM7 [5,15], and mutation within this motif causes a significant reduction in signaling activity [15,16]. The third residue of helix 8 is commonly hydrophobic (Phe, Ile, Val, etc.) in mammalian class A GPCRs, including ORs that comprise the largest superfamily [17]. In the inactive state of GPCR, the Tyr-Phe/Ile/Val intramolecular interaction forms part of the hydrophobic core between helix 8 and TM1–2 [5,15], which stabilizes the orientation and position of the N-terminal region of helix 8 [7].
To investigate the structural details of mOR-S6 using alanine scanning mutagenesis, a model for the 3D structure was constructed by homology modeling (Figure 2) [7] with crystal structures of active Rhod (the Protein Data Bank (PDB) id 3PQR) and β2AdR (PDB id 3SN6) as templates. The best model was chosen based on the discrete optimized protein energy (DOPE) score (statistical score derived from atom pairing frequencies in the PDB) using MODELLER 9.1 [18], and the model was further validated by PROCHECK (ver. 3.5) [19]. In both Rhod and β2AdR structures, the C-terminal amphipathic helix 8 is stabilized by a hydrophobic core on the intracellular side of the membrane [12,13]. Similarly, in our homology model, the hydrophobic core of both the N-terminal linker (Thr300) and helix 8 (Ile303, Leu307, Val308, Leu310 and Phe311) of mOR-S6 are surrounded by TM1 (Phe44, Leu48, and Thr52), IL1 (Leu59) and TM2 (Tyr64). The hydrophobic residues of helix 8 can be categorized into two groups: The first group contains Thr300, Ile303, and Leu307, which are located at the N-terminal side and the middle region of helix 8. These residues play a crucial role in appropriately positioning helix 8, and mutation of these residues likely disrupt the hydrophobic core and prevent activation of Gα. Indeed, in our alanine-scanning mutagenesis analysis of helix 8, mutation of I303A in mOR-S6, equivalent to Phe332 in β2AdR, caused a drastic decrease in agonist-induced Ca2+ responses in HEK293 cells (Figure 3) [7]. This result indicates that disruption of the hydrophobic interactions between Ile303 and Thr300 (N-terminal linker), Leu307 (helix 8) and Leu59 (IL1) lead to impaired activation of Gα by mOR-S6. The third residue of helix 8, Ile303 in mOR-S6, appears to be essential for stabilizing the structure of helix 8, and it is also essential for Gα activation along with Thr300, the last residue of the N-terminal linker region. Alanine mutations T300A and L307A led to drastic and moderate decreases in Ca2+ responses, respectively, since the effect of mutating the N-terminus was greater than that of the middle region (Figure 2 and Figure 3) [7]. Scanning mutagenesis of the M1 muscarinic acetylcholine receptor (M1R, specific to Gq, a member of the Gq/11) similarly indicated that hydrophobic core residues are functionally important [20].
In order to identify GPCR residues responsible for specific interaction with Gα, we investigated the kinetics of agonist-induced cellular Ca2+ responses of mOR-S6 by comparing chimeric Gα15_olf with Gα15. The chimeric Gα15_olf has the Gαolf (a member of the Gs class) C-terminal 376KQYE motif instead of the corresponding 369DEIN sequence present in Gα15 (a member of the Gq/11 class), and this change improves the rapidity of the response (2.2-fold shorter Ca2+ response onset latency) as well as the response amplitude (1.7-fold), compared with Gα15 [7,23]. As expected, EC50 values for the most potent agonist of mOR-S6 showed no significant difference between Gα15_olf and Gα15 [23]. These results indicate that the observed improvements in kinetics are likely attributable to specific interactions at the C-terminal region of Gα15_olf with ORs. In β2AdR, Arg131 of the DRY motif is packed against the fourth residue (Tyr391) of the C-terminal region of Gαs [5]. This intimate interaction between mOR-S6 DRY-motif Arg126 and Gα15_olf C-terminal fourth Tyr371 is believed to be responsible for the rapid and robust responses of ORs with Gα15_olf. During the initial interaction step, conformational heterogeneity of TM7 in agonist-bound β2AdR [24] may facilitate interactions between the Gα C-terminal domain and the GPCR TM7 helix 8. Further kinetic analysis to unequivocally define the residues responsible for the specific interactions between GPCRs and G proteins are discussed in Section 5 below.
The second group of mOR-S6 helix 8 hydrophobic residues includes Leu310 and Phe311, located at the C-terminal interface between helix 8 and TM1. Alanine mutants L310A and F311A of mOR-S6 caused moderate and dramatic decreases in Ca2+ responses with Gα15_olf, respectively, compared with mOR-S6 (Figure 3). Weakening of the hydrophobic core in the vicinity of the helix 8 C-terminal region likely increases helix 8 flexibility and destabilizes its structure. This suggests that activation of Gα15_olf requires a solid and stable helix 8, whereas activation of Gα15 does not have this requirement. In total, seven and five of helix-8 alanine mutants reduced the signaling of mOR-S6 via Gα15_olf and Gα15, respectively (Figure 3). Immunostaining of N-terminal rhodopsin-tagged mOR-S6 with anti-rhodopsin antibody confirmed that all mOR-S6 mutants were efficiently expressed and membrane-localized [7].
4. Shared Features of Different GPCR–G Protein Interactions in Inactive and Active States
In the intra- and inter-molecular interactions of GPCRs that occur during activation and inactivation, the relative position of conserved motifs and residues is clearly important. Key residues controlling GPCR–G protein coupling are believed to be located at the intracellular end of TM5, the N-terminal region of intracellular loop 3 (IL3), the junction of TM3 (including the DRY motif) and IL2, the C-terminal TM6, and the junction of TM7 and helix 8 [4,5,6,21,22]. Comparison of structural differences between inactive and active states of class A GPCRs indicates shared features in the structural rearrangement of activated GPCRs (Figure 1) [3,4]. In β2AdR (specific to Gs, a member of the Gs class), Rhod (specific to Gt, a member of the Gi/o class), μ-opioid receptor (µOR, specific to Gi, a member of the Gi/o class) and M2 muscarinic receptor (M2R, specific to Gi), Arg3.50 of the DRY motif interacts with either Glu6.30 or Thr6.34 in the inactive states (except for M2R and β2AdR), but similarly with Tyr5.58 in all active states (x.yz numbers follow the Ballesteros-Weinstein numbering method for GPCRs [25]) (Figure 1, Arg131–none → Tyr219 in β2AdR; Arg135–Glu247 → Tyr223 in Rhod; Arg165–Thr279 → Tyr252 in µOR) [3]. Tyr7.53 of the NPxxY motif and the adjacent Cys/Ile/Ala7.54 also interact with the third (Phe8.50) and fourth (Arg/Lys8.51) residues of helix 8 respectively, in the inactive states [4,14,15], whereas Tyr7.53 interacts with Tyr5.58 and Leu3.43 through a water-mediated polar network in active state structures (Figure 1, Tyr326–Phe332 → Tyr219 + Leu124 and Cys327–Arg333 → none in β2AdR; Tyr306–Phe313 → Tyr223 + Leu128 and Ile307–Arg314 → none in Rhod; Tyr336–Phe343 → Tyr252 + Leu158 and Ala337–Lys344 → none in µOR) [3]. In our scanning mutagenesis analysis, mutation of the mOR-S6 helix-8 fourth residue (R8.51A) resulted in a drastic decrease in Ca2+ responses for both Gα15_olf and Gα15 (Figure 3) [7]. This is consistent with previous reports that β2AdR Arg8.51333 [6] and β1 adrenergic receptor Arg8.51384 [12] are essential for coupling with G proteins. Notably, recent analysis has indicated that Ile/Leu/Met3.46 interacts with Leu/Val/Ile6.37 in inactive states, but with Tyr7.53 in active states (Figure 1, Ile127–Leu275 → Tyr326 in β2AdR; Leu131–Val254 → Tyr306 in Rhod; Met161–Val282 → Tyr336 in µOR) [4].
A key feature of β2AdR activation is the ~14 Å outward movement of the intracellular portion of TM6, creating a cavity large enough to accommodate the C-terminus of Gα [5,26]. The active state of β2AdR is stabilized by extensive interactions with Gα [5]. In an atomic resolution structure of the β2AdR-Gs complex, the essential and stable interface buried between activated β2AdR and Gαs is formed by IL2, TM5 and TM6 of β2AdR and by helix-α5, the αN-β1 junction, the top of strand β3 strand, and helix-α4 of Gαs [5]. Among the most conserved amino acids, β2AdR Arg131 (TM3 DRY motif) is packed against both Gαs Tyr391 (helix-α5, fourth residue from the C-terminus of Gαs) and β2AdR Tyr326 (TM7 NPxxY motif) [5]. β2AdR Leu275 (TM6) also interacts with Gαs Leu393 (the penultimate residue for the C-terminus) [5,26]. In addition, β2AdR Phe139 (IL2) docks into a hydrophobic pocket formed by Gαs His41 (β1-strand), Val217 (β3-strand), Phe376 (helix-α5), Cys379 (helix-α5), Arg380 (helix-α5) and Ile383 (helix-α5) [5]. The position of Phe139 (IL2) is stabilized by interactions between Asp130 (DRY motif) and Tyr141 (IL2) [5]. Notably, the residue corresponding to Phe139 is a Phe or Leu in almost all Gs-coupled GPCRs [5]. In the crystal structure of Rhod in complex with the Gαt C-terminal peptide (GαCT2), the Rhod D(E)RY motif Arg135 forms a hydrogen bond to the backbone carbonyl oxygen at the fourth residue from the C-terminus of GαCT2 in the C347V mutant [22], which is similar to the packing of the β2AdR DRY motif Arg131 against Gαs Tyr391. However, rather than Arg135, Rhod D(E)RY motif Glu134 binds to NPxxY motif Asn302 via a water-mediated polar network [22].
The results of a solution-state nuclear magnetic resonance (NMR) study raised the possibility that the propagation of conformational changes in GPCRs occurs via initial interactions between GPCR helix 8 and the associated G protein [27]. Using C13-dimethylated µOR, NMR spectroscopy revealed that the agonist-induced spectral changes in helix 8 (Lys8.51344) and IC1 (Lys98, Lys100) were larger than those of TM6 (Lys6.24269/Lys6.26271) and TM5 (Lys5.66260). Interestingly, the presence of both an agonist and a Gαi-mimetic nanobody resulted in a complete loss in the intensity of peaks corresponding to helix 8 and the IC1 Lys residue, and a drastic reduction in the intensity of the TM6 Lys peak, with a concomitant appearance of new intense peak. The spectral shift in the TM6 Lys peak presumably reflects the >10 Å outward movement of TM6 in the active state. Sharp, narrow intense peaks for TM6 and TM5 Lys residues indicate a relatively stable conformation for these features, while broad and irregular peaks for helix 8 and IC1 suggest that two or more conformations of helix 8 and IC1 exchange on a low ms time scale in µOR in the presence of agonist alone [27]. In contrast to the relatively stable positions of TM6 and TM5, helix 8 is likely to be more flexible and thus able to adopt the required conformations for forming specific interactions with Gα C-terminal residues, as will be described in the next section.
5. Helix 8 N-Terminal Residues of GPCRs Are Responsible for Rapid Kinetics Associated with Specific G Protein Activation
Establishing which residues of GPCRs are responsible for the specific interactions with G proteins has received considerable attention. Chimeric mutants of Rhod in which 300NKQ is replaced with the 330SPD sequence of β2AdR (the middle of which is the first amino acid of helix 8) displayed a dramatic decrease in the ability to activate the target Gt [28,29]. Furthermore, we examined the contribution made by each residue of helix 8 of mOR-S6 to the response kinetics using alanine-scanning mutagenesis. Four mutations (E302A, Q305A, L310A, and F311A) caused a decrease in agonist-induced Ca2+ responses in HEK293 cells via Gα15_olf, but not via Gα15 (Figure 3) [7]. Of these four residues, only mutation of Glu302 to alanine resulted in no significant difference in the amplitude of the Ca2+ response between Gα15_olf and Gα15, but a significant difference in response onset latency was still apparent (Figure 4) [7]. Interestingly, this second residue of helix 8 is negatively charged (Glu or Asp) or uncharged, but is polar (Gln) in the OR family (Table 1).
Table 1.
Subclass ORs | Helix-8 Second Residue | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
All | Glu | Gln | Asp | Lys | His | Ala | Pro | Tyr | Val | misc | |
Human class-I ORs | 52 | 12 | 36 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 1 |
100% | 23% | 69% | 0% | 2% | 2% | 0% | 2% | 0% | 0% | 2% | |
Murine class-I ORs | 123 | 29 | 83 | 0 | 5 | 0 | 0 | 3 | 0 | 3 | 0 |
100% | 24% | 67% | 0% | 4% | 0% | 0% | 2% | 0% | 2% | 0% | |
Human class-II ORs | 322 | 155 | 22 | 128 | 6 | 2 | 3 | 0 | 1 | 1 | 4 |
100% | 48% | 7% | 40% | 2% | 1% | 1% | 0% | 0% | 0% | 1% | |
Total human ORs | 374 | 167 | 58 | 128 | 7 | 3 | 3 | 1 | 1 | 1 | 5 |
100% | 45% | 16% | 34% | 2% | 1% | 1% | 0% | 0% | 0% | 1% |
We examined the effect of introducing a positively charged residue in the E302K mutant, and the improved kinetics of the onset latency and amplitude with Gα15_olf were completely abolished in this variant, which showed no significant differences from wild-type mOR-S6 with Gα15 (Figure 4) [7]. These results suggest that the N-terminal acidic residue of helix 8 of an OR is responsible for rapid activation of Gα15_olf. In the crystal structure of the opsin–Gαt C-terminal peptide (GαCT) complex, the second residue of helix 8 (Gln312) interacts with the sixth residue from the C-terminus of Gαt (Lys345) and the opsin helix-8 N-terminal linker residue Asn310, in addition to the interaction between the opsin D(E)RY motif Arg135 and the fourth residue from the C-terminus of Gαt (Cys347) (Figure 1) [30]. Molecular modeling revealed differences between intermediary (R*–Gt(GDP) complex) and stable (R*–Gt(empty) complex) interactions [31]. Specifically, the second residue of helix 8 of Rhod (Gln312) interacts in an intermediate manner with the fourth residue from the C-terminus of Gαt (Cys347), but then stably interacts with the sixth residue from the C-terminus (Lys345). However, in the crystal structures of the Rhod–GαCT2 complex and the stable β2AdR–Gs complex, no such interaction between the second residue of helix 8 and Gα was observed. This difference is likely attributable to the C347V mutation of GαCT2 and the stable (i.e., not intermediate) active state of β2AdR, respectively. Taken together, these observations indicate that the initial transient and specific interaction between the second residue of mOR-S6 helix 8 (Glu302; Gln312 in opsin) and the sixth residue from the C-terminus of Gα15_olf (Lys369; Lys345 in Gαt) likely facilitates the rapid formation of the active state in the OR–Gα15_olf complex, but not in the OR–Gα15 complex. If this is the case, the question arises as to which residues of mOR-S6 initially interact with Gα15.
Notably, the KE301-302EK double mutant of mOR-S6 exhibits an impaired Ca2+ response via both Gα15_olf and Gα15 (our unpublished data). Moreover, mutation of the first residue of helix 8 of mOR-S6 (Lys301), which is conserved in the OR family, resulted in mutants that displayed a complicated behavior [7]. The K301A mutation resulted in a significant, but not drastic, decrease in Ca2+ responses via Gα15 but no change in the responses via Gα15_olf (Figure 3). Meanwhile, the K301A mutation delayed the onset latency, consistent with the decreased response via Gα15 but no change via Gα15_olf (Figure 4). Mutation to an uncharged polar residue (K301Q) resulted in similar changes to K301A in terms of response kinetics. However, in contrast to the KE301-302EK double mutant and the K301A/Q mutants, the K301E single mutant with a negatively charged residue, displayed a drastic and selective decrease in response to Gα15, but not for Gα15_olf. These results raised the possibility that Lys301 may attract a negatively charged region of Gα15, but not necessarily for Gα15_olf. Based on sequence differences between Gα15_olf 369KQYE and Gα15 369DEIN, Gα15 Asp369 and/or Glu370 might be involved in such an initial attraction. In the M3 muscarinic acetylcholine receptor (M3R, specific to Gq/11), an agonist-induced increase in disulfide cross-linking of the first residue of helix 8 (via the K548C mutant) and the α4/β6 loop of Gq (via the D321C mutant) was observed, and was greatly reduced by the pretreatment of membranes with the inverse agonist, atropine [32]. This indicates an interaction between M3R helix 8 Lys548 and Gq α4/β6 loop Asp321. Similarly, mOR-S6 helix 8 Lys301 may interact with Gα15 α4/β6 loop Asp328 with slower response kinetics than the inter-helix interaction between mOR-S6 and Gα15_olf, while the K301E mutation may impair the interaction with Gα15 and hence decrease its activation. Thus, kinetic analysis is very useful for evaluating specific interactions between GPCRs and G proteins.
As described above, transient interactions between the second residue of mOR-S6 helix 8 (Glu302) and the sixth residue from the C-terminus of Gα15_olf (Lys369) likely facilitate the rapid formation of a more stable and active OR–Gα15_olf complex, resulting in a rapid and robust Ca2+ response. If this is the case, the question arises as to exactly how mOR-S6 helix 8 accommodates the Gα α5 C-terminal region between TM3 and TM5 in the stable and active state. Considering the simplest case of β2AdR (mOR-S6) and its relative movement toward Gα, the C-terminus of Gα α5 may forward towards the N-terminal region of β2AdR (mOR-S6) helix 8 under TM domain assembly from the intracellular spacing between TM3 and TM5. This relative movement is likely the trigger for an outward movement of the intracellular portion of TM6 that resides on the front side of the N-terminus of helix 8 and may be ready to move following rearrangement of the TM domains upon agonist binding to β2AdR. A forward movement of the C-terminal region of Gα α5 would then promote its docking onto the N-terminus of β2AdR (mOR-S6) helix 8, resulting in the formation of a specific interaction between the sixth residue from the C-terminus of Gαs (Arg389 in helix-α5; Lys369 of Gα15_olf) and the second residue of β2AdR helix 8 (Asp331; Glu302 in mOR-S6) at the corner of helix 8 and the membrane surface, rather than at the open surface of helix 8 (the first residue of this region, Figure 2). This step also facilitates the breakage of the interaction between the NPxxY motif Tyr7.58326 (Tyr7.58296 of mOR-S6) and the third residue of helix 8 (Phe8.50332; Ile8.50304? of mOR-S6), which is caused by the outward movement of the adjacent Asp331 due to the forward momentum of the transiently interacting C-terminal region of Gα. This presumably results in the movement of helix 8 and Gα C-terminus being pushed back towards TM3 through intra-TM interactions that underpin the elastic properties. This likely results in intimate interactions between β2AdR TM3 DRY-motif Arg131 and both the fourth residue from the C-terminus of Gαs (Tyr391) and β2AdR NPxxY motif Tyr326, which stabilizes the active state of the ternary complex [5]. These proposed transient perturbations of helix 8 are consistent with the moderately dynamic conformational changes observed for C13-dimethylated µOR [27].
This model also explains the greater selective decrease in the Ca2+ response for Gα15_olf observed in mOR-S6 F311A compared with the L310A mutant, since weakening of the hydrophobic core at the C-terminus of helix 8 likely increases its flexibility and destabilizes the position of Glu302 between the membrane and the open surface to a greater extent than disruption of the hydrophobic core within the middle of helix 8. This model, therefore, offers a possible explanation for the rapid formation of a more stable ternary GPCR–G protein complex. Truncated mutants provide further support that helix 8 is essential in GPCR signaling [7,33].
Notably, molecular dynamics simulation and mutagenesis studies of the cannabinoid 1 (CB1, specific to Gi) receptor suggested that Arg400 (the penultimate amino acid of the N-terminal linker) interacts with the penultimate residue of Gαi (Leu353) [34]. The penultimate Leu393 point mutation to Ala in Gαs also reduced the activity of both β2AdR and luteinizing hormone receptor (LHR) [35]. Furthermore, in our scanning mutagenesis analysis, two mutations of this CB1 Arg400 equivalent (R299A and R299E), respectively, markedly reduced and completely ablated the Ca2+ response [7]. These results suggest that the penultimate residue of the N-terminal linker between helix 8 and TM7 might be responsible for the recruitment of the G protein C-terminus.
6. The Second Residue of Helix 8 Partially Governs the Hierarchy of GPCR-Associated Information in Parallel GPCR Signaling Pathways
The replacement of Gα15 369DEIN with Gαolf 376KQYE improved the response kinetics of mOR-S6 via the chimeric Gα15_olf by shortening the onset latency 2.2-fold [7,23], but replacement of mOR-S6 Glu302 with Arg302 completely eliminated the effect of this mutation on mOR-S6-mediated Ca2+ responses [7]. These findings clearly indicate that the second residue of helix 8 is a major determinant of the initial specific interaction with the target G protein that are essential for a rapid and robust response, rather than with Arg or Ala at the second position of helix 8 in ORs or non-target G proteins. In the olfactory system, the second residue of helix 8 appears to govern the sensory processing hierarchy of elemental odors that are represented in the third-order neurons of olfactory pathways [36,37,38,39].
We proposed a mechanism for supersensitive odor discrimination wherein signals from the helix 8 second residue Glu of dorsal ORs determines the most prominent elemental odor of a given odorant [36]. In odor detection/discrimination behavioral assays, wild-type mice can discriminate similar odors of enantiomeric pairs at sub-ppq (<10−15) level, which equates to supersensitivity for enantiomer detection, whereas transgenic mice in which all dorsal ORs are ablated display a >1010-fold reduction in enantiomer discrimination sensitivity, although the supersensitive detection capability for (−)-enantiomers is retained [37]. This result indicates that the most sensitive ORs that enable the transgenic mice to detect (−)-enantiomers but not (+)-enantiomers at sub-ppq level do not allow the mice to discriminate (−) from (+)-enantiomers with supersensitivity (odor discrimination paradox), and suggests that some of the most sensitive ORs ablated may enhance characteristic elemental odors in wild-type mice. Among the ablated dorsal ORs with a Glu in the second position of helix 8, mOR-car-c5 is one of the most sensitive and specific for (R)-(−)-carvone (Figure 5). These results indicate that the highly sensitive helix-8-second-Glu dorsal ORs play a critical role in hierarchical elemental odor coding by summating synchronized inputs from cognate ORs to third-order neurons for elemental odors through feedforward inhibition [37].
The hierarchical odor-coding hypothesis was first proposed following receptor code analysis for carvone enantiomers [38]. This odor-decoding model considers that the olfactory system can extract sensory information by summating signals from multiple receptors in the third-order neurons of olfactory pathways via input synchronization through feedforward inhibition of the pyramidal cells in the anterior piriform cortex (aPC), the second olfactory center [36,37,39]. This sensory strategy is analogous to that in vision, wherein the four elemental colors (red, green, yellow and blue) are primarily extracted by the third-order neurons (ganglion cells) or the higher visual pathway through summation of synchronized inputs from one or two types of receptors following inhibition by signals from M-cone and S-cone photoreceptors. Elemental colors allow us to perceive all visible hues in different weighted combinations, and similarly, elemental odors likely allow us to discriminate various odors in different weighted combinations.
Olfactory feedforward inhibition is activated in the rostro-ventral portion of the aPC (aPCvr) [40]. Notably, in insects, input synchronization via inhibition is also important for discrimination of similar odors [41]. Furthermore, mutual inhibition between different odors was previously examined in a mixture of rose and fox-unique TMT odors in mice [42]. A rose-odor-induced decrease was apparent in cells positive for the TMT odor in the aPCvr, and this was accompanied by a subsequent decrease in the TMT-induced stress response. This suggests that signals from ORs activated by the co-applied rose odor weakens the feedforward inhibition from ORs for TMT and thus weakens the subsequent signal integration of cognate TMT ORs. Compared to the sum of the responses to the two individual odors, the total number of cells positive for the mixture of TMT and rose odor in the dorsal part of the anterior piriform cortex also decreased, suggesting a decrease in the perceived intensity of the TMT odor [42]. In contrast to the rose odor, caraway odor did not alleviate the TMT-induced stress response, suggesting a hierarchy of elemental odors in the order rose > TMT > caraway, at least under the experimental conditions employed. Signals from helix-8-second-Glu dorsal ORs are likely associated with the most prominent (upper level) signaling for a given odor (the most prominent elemental odor), whereas other ORs are presumably related to lower levels (auxiliary) of the odor (weaker elemental odors).
In this way, helix-8-second-Glu of ORs appear to govern, at least in part, olfactory information processing of hierarchical elemental odors through earlier and more intense signals than those processed by helix-8-second-Ala or Lys ORs in parallel GPCR signaling pathways. Among 374 (52 class I and 322 class II) human ORs, a total of 45% (23% (12/52) in class I and 48% (155/322) in class II) have a Glu at the second position of helix 8, while the 33% and 16% have an Asp and Gln, respectively (Table 1). Interestingly, Glu and Gln are identical in terms of side-chain size (i.e., they are isosteric). However, although Glu and Asp both have a negative charge, the side chain of Asp is shorter by one carbon atom, and there are no helix-8-second-Asp ORs among human or murine class-I ORs that are expressed in the dorsal zone (dorsal ORs). Moreover, the frequency of helix-8-second-Glu, Asp and Gln ORs are almost identical between human and murine class-I ORs: 23% vs. 24%, 0% vs. 0% and 69% and 67%, respectively (Table 1). Helix-8 second residues were >90% (39/42 and 204/226 in class I and II, respectively) identical between human and murine ORs (Table S1). These results suggest that ORs with different residues at the second position of helix 8 play distinct roles in elemental odor representation. As described above, our results suggest that the most sensitive helix-8-second-Glu dorsal ORs emphasize (R)-(−)-carvone-unique elemental odors in the brain by selective summation of cognate OR signals via synchronized inputs to the third-order neurons through feedforward inhibition driven by signals from the most sensitive helix-8-second-Glu dorsal ORs with a shorter onset latency (one of which is enclosed by the red rectangular in Figure 5) [36,37]. If ORs with longer onset latencies determine the most prominent elemental odors, odor perception must change during development as odor representation in the brain adapts over time.
Furthermore, helix-8-second-Glu ORs accounted for 73% (11/15) of the 15 identified carvone ORs in a single-cell RT-PCR study of 2740 randomly sampled murine olfactory sensory neurons, which is 1.6-fold more than the average number of human helix-8-second-Glu ORs. Along with the absence of any helix-8-second-Asp class-I ORs in both human and mouse, this indicates that helix-8-second-Glu ORs operate as determinants of odor representation. Interestingly, helix-8-second-Gln class-I ORs make up the largest group (67%–69%), which is ca. 3-fold and 10-fold larger than helix-8-second-Glu class-I ORs and helix-8-second-Gln class-II ORs, respectively. Future research should focus on the question of which target-prominent or auxiliary elemental odors different types of ORs contribute to identifying, amplifying or classifying.
7. Potential Roles of Helix 8 in GPCR Membrane Surface Expression, Internalization, Regulation of Phosphorylation and Dimerization
In parallel GPCR signaling pathways, a proper ratio of signaling proteins is likely required for ensuring adequate sensory information processing or systematic functional regulation. Inhibition of GPCRs by phosphorylation of the C-terminal region may disrupt the proper sequence of multistep interactions between GPCRs and their target G proteins, resulting in their removal from the membrane. Non-interactive GPCR mutants must also be removed because they could reduce the total GPCR sensitivity by capturing target agonists, leading to a decrease in the effective agonist concentration. Arrestin-mediated internalization of phosphorylated GPCRs is likely to be one of the regulatory mechanisms employed to maintain the proper sensitized/desensitized GPCR ratio.
In the thyrotropin-releasing hormone receptor (TRHR, specific to Gq/11), agonist-dependent phosphorylation by GPCR kinases occurs in both wild type (>35%) and helix-8-second K326R mutant forms (ca. 40%) but not in the K326Q mutant (ca. 5%) [43]. In total, 70% of wild-type TRHR was internalized following complex formation with arrestin, but internalization was only 40% for 6K → 6Q mutant (including helix-8-second-Lys). The high internalization rate suggests that wild-type TRHR may be of less importance than the 6K → 6Q TRHR mutant, or overexpressed to a great extent than could be measured accurately. This also suggests that the G protein coupling specificity-determining second residue of helix 8 is also a determinant of receptor phosphorylation and internalization via formation of arrestin-receptor complexes. When Rhod is phosphorylated in the C-terminal region, the conformational dynamics of helix 8 controls binding to arrestin and subsequent arrestin activation during the desensitization process [44]. Enhancement of agonist-induced receptor internalization by a single mutation in helix 8 has also been reported for the human calcitonin receptor-like receptor [10].
In melanin-concentrating hormone receptor 1, a proximal dibasic pair of residues in the fourth and fifth positions of helix 8 is required for GPCR cell surface expression and signaling [45]. Furthermore, in the type 1 angiotensin receptor, helix 8 has been reported to interact with a myriad of proteins, including caveolin, angiotensin II type 1 receptor-associated protein, and γ-aminobutyric acid receptor-associated protein in membrane expression, G proteins, phospholipase C, Jak2, calmodulin and SHP-2 in signaling, and regulators in lateral receptor migration, receptor internalization and nuclear transcription factors [46]. Helix 8 also plays a key role in protein/lipid interactions [8,9] and dimerization of receptors [11] or heteroreceptors (fibroblast growth factor receptor 1 and 5-hydroxytryptamine 1A receptor that play an enhancing role in hippocampal plasticity) [47], and is, therefore, responsible for multiple functions in parallel GPCR signaling pathways.
Acknowledgments
This work was supported in part by Grants-in-Aid for Scientific Research (#15H02730 to Takaaki Sato and Takashi Kawasaki; #26102526 and #16H00738 to Hiroyoshi Matsumura from the Japan Society for the Promotion of Science, and grants from Ministry of Economy, Trade and Industry, Japan to Takaaki Sato, Takashi Kawasaki, and Shouhei Mine.
Supplementary Materials
Supplementary materials can be found at www.mdpi.com/1422-0067/17/11/1930/s1.
Author Contributions
Takaaki Sato, Takashi Kawasaki, Shouhei Mine and Hiroyoshi Matsumura wrote the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Bjarnadóttir T.K., Gloriam D.E., Hellstrand S.H., Kristiansson H., Fredriksson R., Schiöth H.B. Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics. 2006;88:263–273. doi: 10.1016/j.ygeno.2006.04.001. [DOI] [PubMed] [Google Scholar]
- 2.Overington J.P., Al-Lazikani B., Hopkins A.L. How many drug targets are there? Nat. Rev. 2006;5:993–996. doi: 10.1038/nrd2199. [DOI] [PubMed] [Google Scholar]
- 3.Huang W., Manglik A., Venkatakrishnan A.J., Laeremans T., Feinberg E.N., Sanborn A.L., Kato H.E., Livingston K.E., Thorsen T.S., Kling R.C., et al. Structural insights into μ opioid receptor activation. Nature. 2015;524:315–321. doi: 10.1038/nature14886. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Venkatakrishnan A.J., Deupi X., Lebon G., Heydenreich F.M., Flock T., Miljus T., Balaji S., Bouvier M., Veprintsev D.B., Tate C.G., et al. Diverse activation pathways in class A GPCRs converge near the G protein-coupling region. Nature. 2016;536:484–487. doi: 10.1038/nature19107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rasmussen S.G., DeVree B.T., Zou Y., Kruse A.C., Chung K.Y., Kobilka T.S., Thian F.S., Chae P.S., Pardon E., Calinski D., et al. Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature. 2011;477:549–555. doi: 10.1038/nature10361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kling R.C., Lanig H., Clark T., Gmeiner P. Active-state models of ternary GPCR complexes: Determinants of selective receptor-G protein coupling. PLoS ONE. 2013;8:e67244. doi: 10.1371/journal.pone.0067244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kawasaki T., Saka T., Mine S., Mizohata E., Inoue T., Matsumura H., Sato T. The N-terminal acidic residue of the cytosoloc helix 8 of an odorant receptor is responsible for different response dynamics via G protein. FEBS Lett. 2015;589:1136–1142. doi: 10.1016/j.febslet.2015.03.025. [DOI] [PubMed] [Google Scholar]
- 8.Bruno A., Costantino G., de Fabritiis G., Pastor M., Selent J. Membrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCR. PLoS ONE. 2012;7:e42023. doi: 10.1371/annotation/b3d4540a-9b4b-4855-b570-6324b40232fe. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Krishna A.G., Menon S.T., Terry T.J., Sakmar T.P. Evidence that helix 8 of rhodopsin acts as a membrane-dependent conformational switch. Biochemistry. 2002;41:8298–8309. doi: 10.1021/bi025534m. [DOI] [PubMed] [Google Scholar]
- 10.Kuwasako K., Kitamura K., Nagata S., Hikosaka T., Kato J. Structure-function analysis of helix 8 of human calcitonin receptor-like receptor within the adrenomedullin 1 receptor. Peptides. 2011;32:144–149. doi: 10.1016/j.peptides.2010.10.005. [DOI] [PubMed] [Google Scholar]
- 11.Knepp A.M., Periole X., Marrink S.J., Sakmar T.P., Huber T. Rhodopsin forms a dimer with cytoplasmic helix 8 contacts in native membranes. Biochemistry. 2012;51:1819–1821. doi: 10.1021/bi3001598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Delos Santos N.M., Gardner L.A., White S.W., Bahouth S.W. Characterization of the residues in helix 8 of the human β1-adrenergic receptor that are involved in coupling the receptor to G proteins. J. Biol. Chem. 2006;281:12896–12907. doi: 10.1074/jbc.M508500200. [DOI] [PubMed] [Google Scholar]
- 13.Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science. 2007;318:1258–1265. doi: 10.1126/science.1150577. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000;289:739–745. doi: 10.1126/science.289.5480.739. [DOI] [PubMed] [Google Scholar]
- 15.Fritze O., Filipek S., Kuksa V., Palczewski K., Hofmann K.P., Ernst O.P. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc. Natl. Acad. Sci. USA. 2003;100:2290–2295. doi: 10.1073/pnas.0435715100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Hamamoto A., Horikawa M., Saho T., Saito Y. Mutation of Phe318 within the NPxxY(x)(5,6)F motif in melanin-concentrating hormone receptor 1 results in an efficient signaling activity. Front. Endocrinol. 2012;3:147. doi: 10.3389/fendo.2012.00147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Buck L., Axel R. A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell. 1991;65:175–187. doi: 10.1016/0092-8674(91)90418-X. [DOI] [PubMed] [Google Scholar]
- 18.Sali A., Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
- 19.Laskowski R., MacArthur M., Moss D., Thornton J. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Cryst. 1993;26:283–291. doi: 10.1107/S0021889892009944. [DOI] [Google Scholar]
- 20.Kaye R.G., Saldanha J.W., Lu Z.L., Hulme E.C. Helix 8 of the M1 muscarinic acetylcholine receptor: Scanning mutagenesis delineates a G protein recognition site. Mol. Pharmacol. 2011;79:701–709. doi: 10.1124/mol.110.070177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., et al. Crystal structure of the human β2 adrenergic G protein-coupled receptor. Nature. 2007;450:383–387. doi: 10.1038/nature06325. [DOI] [PubMed] [Google Scholar]
- 22.Choe H.W., Kim Y.J., Park J.H., Morizumi T., Pai E.F., Krauss N., Hofmann K.P., Scheerer P., Ernst O.P. Crystal structure of metarhodopsin II. Nature. 2011;471:651–655. doi: 10.1038/nature09789. [DOI] [PubMed] [Google Scholar]
- 23.Hamana H., Shou-Xin L., Breuils L., Hirono J., Sato T. Heterologous functional expression system for odorant receptors. J. Neurosci. Methods. 2010;185:213–220. doi: 10.1016/j.jneumeth.2009.09.024. [DOI] [PubMed] [Google Scholar]
- 24.Nygaard R., Zou Y., Dror R.O., Mildorf T.J., Arlow D.H., Manglik A., Pan A.C., Liu C.W., Fung J.J., Bokoch M.P., et al. The dynamic process of β2-adrenergic receptor activation. Cell. 2013;152:532–542. doi: 10.1016/j.cell.2013.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ballesteros J.A., Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Method Neurosci. 1995;25:366–428. [Google Scholar]
- 26.Kruse A.C., Ring A.M., Manglik A., Hu J., Hu K., Eitel K., Hübner H., Pardon E., Valant C., Sexton P.M., et al. Activation and allosteric modulation of a muscarinic acetylcholine receptor. Nature. 2013;504:101–106. doi: 10.1038/nature12735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Sounier R., Mas C., Steyaert J., Laeremans T., Manglik A., Huang W., Kobilka B.K., Déméné H., Granier S. Propagation of conformational changes during μ opioid receptor activation. Nature. 2015;524:375–378. doi: 10.1038/nature14680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ernst O.P., Meyer C.K., Marin E.P., Henklein P., Fu W.Y., Sakmar T.P., Hofmann K.P. Mutation of the fourth cytoplasmic loop of rhodopsin affects binding of transducin subunits. J. Biol. Chem. 2000;275:1937–1943. doi: 10.1074/jbc.275.3.1937. [DOI] [PubMed] [Google Scholar]
- 29.Marin E.P., Krishna A.G., Zvyaga T.A., Isele J., Siebert F., Sakmar T.P. The amino terminus of the fourth cytoplasmic loop of rhodopsin modulates rhodopsin-transducin interaction. J. Biol. Chem. 2000;275:1930–1936. doi: 10.1074/jbc.275.3.1930. [DOI] [PubMed] [Google Scholar]
- 30.Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krauß N., Choe H.W., Hofmann K.P., Ernst O.P. Crystal structural of opsin in its G protein-interacting conformation. Nature. 2008;455:497–502. doi: 10.1038/nature07330. [DOI] [PubMed] [Google Scholar]
- 31.Scheerer P., Heck M., Goede A., Park J.H., Choe H.W., Ernst O.P., Hofmann K.P., Hildebrand P.W. Structural and kinetic modeling of an activating helix switch in the rhodopsin-transducin interface. Proc. Natl. Acad. Sci. USA. 2009;106:10660–10665. doi: 10.1073/pnas.0900072106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Hu J., Wang Y., Zhang X., Lloyd J.R., Li J.H., Karpiak J., Costanzi S., Wess J. Structural basis of G protein-coupled receptor-G protein interactions. Nat. Chem. Biol. 2010;6:541–548. doi: 10.1038/nchembio.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Katada S., Tanaka M., Touhara K. Structural determinants for membrane trafficking and G protein selectivity of a mouse olfactory receptor. J. Neurochem. 2004;90:1453–1463. doi: 10.1111/j.1471-4159.2004.02619.x. [DOI] [PubMed] [Google Scholar]
- 34.Shim J.Y., Ahn K.H., Kendall D.A. Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: Identification of key CB1 contacts with the C-terminal helix α5 of Gαi. J. Biol. Chem. 2013;288:32449–32465. doi: 10.1074/jbc.M113.489153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.DeMars G., Fanelli F., Puett D. The extreme C-terminal region of Gαs differentially couples to the luteinizing hormone and β2-adrenergic receptors. Mol. Endocrinol. 2011;25:1416–1430. doi: 10.1210/me.2011-0009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Sato T., Kobayakawa R., Kobayakawa K., Emura M., Itohara S., Kawasaki T., Tsuboi A., Matsumura H. Supersensitive odor discrimination is controlled in part by initial transient interactions between the most sensitive dorsal olfactory receptors and G proteins. Recept. Clin. Investig. 2016;3:e1117. [Google Scholar]
- 37.Sato T., Kobayakawa R., Kobayakawa K., Emura M., Itohara S., Kizumi M., Hamana H., Tsuboi A., Hirono J. Supersensitive detection and discrimination of enantiomers by dorsal olfactory receptors: Evidence for hierarchical odour coding. Sci. Rep. 2015;5:14073. doi: 10.1038/srep14073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hamana H., Hirono J., Kizumi M., Sato T. Sensitivity-dependent hierarchical receptor codes for odours. Chem. Senses. 2003;28:87–104. doi: 10.1093/chemse/28.2.87. [DOI] [PubMed] [Google Scholar]
- 39.Sato T., Kajiwara R., Takashima I., Iijima T. A novel method for quantifying similarities between oscillatory neural responses in wavelet time-frequency power profiles. Brain Res. 2016;1636:107–117. doi: 10.1016/j.brainres.2016.01.054. [DOI] [PubMed] [Google Scholar]
- 40.Ishikawa T., Sato T., Shimizu A., de Curtis M., Kakei T., Iijima T. Odour-driven activity in the olfactory cortex of an in vitro isolated guinea-pig whole brain with olfactory epithelium. J. Neurophysiol. 2007;97:670–679. doi: 10.1152/jn.01366.2005. [DOI] [PubMed] [Google Scholar]
- 41.Stopfer M., Bhagavan S., Smith B.H., Laurent G. Impaired odour discrimination on desynchronization of odour-encoding neural assemblies. Nature. 1997;390:70–74. doi: 10.1038/36335. [DOI] [PubMed] [Google Scholar]
- 42.Matsukawa M., Imada M., Murakami T., Aizawa S., Sato T. Rose odour can innately counteract predator odour. Brain Res. 2011;1381:117–123. doi: 10.1016/j.brainres.2011.01.053. [DOI] [PubMed] [Google Scholar]
- 43.Gehret A.U., Jones B.W., Tran P.N., Cook L.B., Greuber E.K., Hinkle P.M. Role of helix 8 of the thyrotropin-releasing hormone receptor in phosphorylation by G protein-coupled receptor kinase. Mol. Pharmacol. 2010;77:288–297. doi: 10.1124/mol.109.059733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Kirchberg K., Kim T.Y., Möller M., Skegro D., Dasara Raju G., Granzin J., Büldt G., Schlesinger R., Alexiev U. Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process. Proc. Natl. Acad. Sci. USA. 2011;108:18690–18695. doi: 10.1073/pnas.1015461108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Tetsuka M., Saito Y., Imai K., Doi H., Maruyama K. The basic residues in the membrane-proximal C-terminal tail of the rat melanin-concentrating hormone receptor 1 are required for receptor function. Endocrinology. 2004;145:3712–3723. doi: 10.1210/en.2003-1638. [DOI] [PubMed] [Google Scholar]
- 46.Huynh J., Thomas W.G., Aguilar M.-I., Pattenden L.K. Role of helix 8 in G protein-coupled receptors based on structure-function studies on the type 1 angiotensin receptor. Mol. Cell. Endocrinol. 2009;302:118–127. doi: 10.1016/j.mce.2009.01.002. [DOI] [PubMed] [Google Scholar]
- 47.Borroto-Escuela D.O., Romero-Fernandez W., Mudó G., Pérez-Alea M., Ciruela F., Tarakanov A.O., Narvaez M., di Liberto V., Agnati L.F., Belluardo N., et al. R Fibroblast growth factor receptor 1–5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biol. Psychiatry. 2012;71:84–91. doi: 10.1016/j.biopsych.2011.09.012. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.